Financials data is unavailable for this security.
View more
Year on year Imagion Biosystems Ltd had net income fall 27.19% from a loss of 9.81m to a larger loss of 12.47m despite a 152.07% increase in revenues from 569.96k to 1.44m.
| Gross margin | -- |
|---|---|
| Net profit margin | -324.91% |
| Operating margin | -484.17% |
| Return on assets | -204.15% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in AUDView more
In 2023, cash reserves at Imagion Biosystems Ltd fell by 4.22m. Cash Flow from Financing totalled 4.29m or 298.71% of revenues. In addition the company used 8.32m for operations while cash used for investing totalled 190.38k.
| Cash flow per share | -0.1656 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.1616 |
|---|---|
| Tangible book value per share | -0.1616 |
More ▼
Balance sheet in AUDView more
| Current ratio | 0.0858 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
